Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.34 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.34 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.34 |
| ▸ | ELANE | P08246 | 1/20 | 0.33 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.32 |
| ▸ | CA12 | O43570 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.31 |
| ▸ | USP2 | O75604 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9299514 | 0.98 | HDAC6 (0.33) | HDAC6HDAC1HDAC2ELANEDGAT1 | |
| SCHEMBL1827760 | 0.83 | HDAC6 (0.36) | HDAC6HDAC1HDAC2ELANEDGAT1 | |
| SCHEMBL27804594 | 0.82 | HDAC6 (0.37) | HDAC6HDAC1HDAC2 | |
| Ethylenediamine SCHEMBL28140303 | 0.81 | HDAC6 (0.36) | HDAC6HDAC1HDAC2ELANEDGAT1 | |
| SCHEMBL28061441 | 0.81 | HDAC6 (0.36) | HDAC6HDAC1HDAC2ELANEDGAT1 | |
| SCHEMBL29004075 | 0.81 | RECQL (0.36) | DGAT1CA12CA2CA14 | |
| SCHEMBL44143 | 0.80 | — | — | |
| SCHEMBL6116105 | 0.80 | — | — | |
| SCHEMBL27544433 | 0.79 | CYP1A2 (0.47) | HDAC6HDAC1HDAC2ELANELMNA | |
| SCHEMBL3695618 | 0.78 | TSHR (0.36) | HDAC6HDAC1HDAC2ELANEDGAT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 508 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119707872-A | Method for amidation of carboxylic acid and continuous flow photochemistry device | 国网安徽省电力有限公司电力科学研究院 | 2025-03-28 | — | — | CN | claimed |
| CN-119504652-A | Method for amidating carboxylic acid and gas-liquid mixed flow photochemical device | 国网安徽省电力有限公司电力科学研究院 | 2025-02-25 | — | — | CN | claimed |
| CN-119504653-A | Carboxylic acid amidation method | 国网安徽省电力有限公司电力科学研究院 | 2025-02-25 | — | — | CN | claimed |
| CN-119144015-A | Preparation method of antibacterial mimetic peptide hydrogel | 淮阴工学院 | 2024-12-17 | — | — | CN | claimed |
| CN-119143934-A | Preparation method of temperature-sensitive antibacterial mimetic peptide hydrogel | 淮阴工学院 | 2024-12-17 | — | — | CN | claimed |
| CN-118580856-A | SUMO-C3H8BrN probe, synthesis method and application | 大连理工大学 | 2024-09-03 | — | — | CN | claimed |
| EP-3908571-A1 | KETAMINE DERIVATIVES AND COMPOSITIONS THEREOF | XWPharma Ltd. (KY) | 2021-11-17 | — | — | EP | claimed |
| WO-2020143198-A1 | KETAMINE DERIVATIVES AND COMPOSITIONS THEREOF | XW LABORATORIES INC. (KY) | 2020-07-16 | — | — | WO | claimed |
| CN-107207562-B | Prodrugs of 17 β -HSD1 inhibitors | 佛恩多制药有限公司 | 2020-03-06 | — | — | CN | claimed |
| CN-109897048-A | 10-Methoxycamptothecine glycinate, preparation method and purposes | 哈尔滨理工大学 | 2019-06-18 | — | — | CN | claimed |
| CN-107207562-A | Prodrugs of 17 beta-HSD 1 inhibitors | 佛恩多制药有限公司 | 2017-09-26 | — | — | CN | claimed |
| CN-105968170-A | Fluorescent probe substrate of dipeptidyl peptidase IV as well as preparation method and application of fluorescent probe substrate | 安阳师范学院 | 2016-09-28 | — | — | CN | claimed |
| CN-102935066-B | Irinotecan liposome preparation and preparation method thereof | QILU PHARMACEUTICAL CO LTD | 2014-09-17 | — | — | CN | claimed |
| CN-102935066-A | Irinotecan liposome preparation and preparation method thereof | QILU PHARMACEUTICAL CO LTD | 2013-02-20 | — | — | CN | claimed |
| CN-102649810-A | Camptothecin derivative and preparation method and application thereof | UNIV NORTHEAST FORESTRY | 2012-08-29 | — | — | CN | claimed |
| EP-2172508-B1 | Process for preparing branched polyamines and formulations thereof for use in medical applications | TYCO HEALTHCARE (US) | 2012-03-28 | — | — | EP | claimed |
| US-20100087668-A1 | Branched Polyamines And Formulations Thereof For Use In Medical Devices | TYCO HEALTHCARE GROUP LP | 2010-04-08 | — | — | US | claimed |
| EP-2172508-A1 | Branched polyamines and formulations thereof for use in medical devices | Tyco Healthcare Group LP (US) | 2010-04-07 | — | — | EP | claimed |
| CN-1303086-C | Compound of dual functional esterified prodrug of Cefetamet, and oral preparation | ZHU XIAOMAO (CN) | 2007-03-07 | — | — | CN | claimed |
| CN-1687076-A | Compound of dual functional esterified prodrug of Cefetamet, and oral preparation | ZHU XIAOMAO (CN) | 2005-10-26 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100087668-A1 | Branched Polyamines And Formulations Thereof For Use In Medical Devices | SRM, PNMT, PARG | HDAC6 1272/4885HDAC1 2099/4885HDAC2 1228/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.